Moderate Weight Loss Reduces Renin and Aldosterone but does not Influence Basal or Stimulated Pituitary-adrenal Axis Function

 

 Buy Article Permissions and Reprints

Abstract

Body fat mass and nutrition influence secretion of the adrenocortical hormones - aldosterone and cortisol - via several mechanisms. However, there are no data on adrenocortical function following widely prescribed mild diet-induced weight loss (10%) in obese subjects. In the present study, 25 healthy obese volunteers (BMI 32.9±4.3 kg/m²) followed a 30% calorie restricted diet over 12 weeks. Hypothalamic-pituitary-adrenal (HPA) axis function was assessed by 24-hour urine free cortisol/cortisone and a 1 mcg ACTH stimulation test with measurement of total and free cortisol and corticosteroid-binding globulin (CBG). The renin-angiotensin-aldosterone system (RAAS) was assessed by measurement of plasma aldosterone and renin under salt depleted (30 mmol/d) and loading (250 mmol/d) conditions. Volunteers’ weight fell by 8.5±0.8 kg (8.9±0.7%) and seated systolic blood pressure fell by 8.7±2.7 mm Hg and diastolic blood pressure by 7.0±1.4 mmHg (p<0.01). Plasma aldosterone and renin levels fell significantly with weight loss (aldosterone: 853±156-635±73 pmol/l; renin: 35.4±7-24±3 mU/l, both p<0.05). The volunteers were relatively salt insensitive (mean arterial pressure change with salt intake: 4 mmHg) and this was not affected by weight loss. Moderate weight loss had no effect on 24-hour urine free cortisol/cortisone, or on basal, or ACTH-stimulated free and total cortisol, or CBG. Hence this conventional weight loss program reduces blood pressure and activity of the RAAS via an effect on renin release. Despite various described influences of fat mass and energy restriction on HPA axis function, there were no changes in basal and stimulated HPA axis function with moderate weight loss. There may be a threshold effect of weight loss/energy restriction required to alter HPA axis function, or moderate weight loss may lead to a counterbalanced effect of stimulatory and inhibitory influences on HPA axis function.

References

• 1 Kannel WB, Garrison RJ, Dannenberg AL. Secular blood pressure trends in normotensive persons: the Framingham Study.  Am Heart J. 1993;  125 1154-1158
  CrossrefPubMedGoogle Scholar
• 2 Aucott L, Poobalan A, Smith WC, Avenell A, Jung R, Broom J. Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review.  Hypertension. 2005;  45 1035-1041
  CrossrefPubMedGoogle Scholar
• 3 Berchtold P, Sims EA, Horton ES, Berger M. Obesity and hypertension: epidemiology, mechanisms, treatment.  Biomed Pharmacother. 1983;  37 251-258
  PubMedGoogle Scholar
• 4 Dornfeld LP, Maxwell MH, Waks A, Tuck M. Mechanisms of hypertension in obesity.  Kidney Int Suppl. 1987;  22 S254-S258
  PubMedGoogle Scholar
• 5 El Atat F, Aneja A, Macfarlane S, Sowers J. Obesity and hypertension.  Endocrinol Metab Clin North Am. 2003;  32 823-854
  CrossrefPubMedGoogle Scholar
• 6 Rocchini AP. Obesity hypertension.  Am J Hypertens. 2002;  15 ((2 Pt 2)) 50S-52S
  CrossrefPubMedGoogle Scholar
• 7 Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion.  Endocrinol Metab Clin North Am. 2002;  31 173-189
  CrossrefPubMedGoogle Scholar
• 8 Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL, Ball DL. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II.  Hypertension. 1990;  15 ((6 Pt 2)) 861-866
  PubMedGoogle Scholar
• 9 Hiramatsu K, Yamada T, Ichikawa K, Izumiyama T, Nagata H. Changes in endocrine activities relative to obesity in patients with essential hypertension.  J Am Geriatr Soc. 1981;  29 25-30
  PubMedGoogle Scholar
• 10 Lamounier-Zepter V, Rotthoff T, Ansurudeen I, Kopprasch S, Scherbaum WA, Ehrhart-Bornstein M. et al . Increased aldosterone/renin quotient in obese hypertensive women: a novel role for low-density lipoproteins?.  Horm Metab Res. 2006;  38 471-475
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Goodfriend TL, Egan BM, Kelley DE. Aldosterone in obesity.  Endocr Res. 1998;  24 ((3-4)) 789-796
  CrossrefPubMedGoogle Scholar
• 12 Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A. et al . Human adipocytes secrete mineralocorticoid-releasing factors.  Proc Natl Acad Sci USA. 2003;  100 14211-14216
  CrossrefPubMedGoogle Scholar
• 13 Schinner S, Willenberg HS, Krause D, Schott M, Lamounier-Zepter V, Krug AW. et al . Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway.  Int J Obes (Lond). 2007;  31(5) 864-870
  PubMedGoogle Scholar
• 14 Krug A, Vleugels K, Schinner S, Lamounier-Zepter V, Ziegler CG, Bornstein SR. et al . Human Adipocytes Induce an ERK1/2 MAPkinases - mediated Upregulation of Steroidogenic Acute Regulatory Protein (StAR) and an Angiotensin II - Sensitization in Human Adrenocortical Cells.  Int J Obes. 2007;  , in press
  PubMedGoogle Scholar
• 15 Marin P, Darin N, Amemiya T, Andersson B, Jern S, Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women.  Metabolism. 1992;  41 882-886
  CrossrefPubMedGoogle Scholar
• 16 Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R. et al . The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.  J Clin Endocrinol Metab. 1993;  77 341-346
  CrossrefPubMedGoogle Scholar
• 17 Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities.  J Clin Endocrinol Metab. 1998;  83 1853-1859
  CrossrefPubMedGoogle Scholar
• 18 Fernandez-Real JM, Pugeat M, Grasa M, Broch M, Vendrell J, Brun J. et al . Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study.  J Clin Endocrinol Metab. 2002;  87 4686-4690
  CrossrefPubMedGoogle Scholar
• 19 Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L, Stewart PM. Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.  J Clin Endocrinol Metab. 2004;  89 2711-2716
  CrossrefPubMedGoogle Scholar
• 20 Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V. et al . The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents.  N Engl J Med. 1989;  321 580-585
  CrossrefPubMedGoogle Scholar
• 21 Yanovski JA, Yanovski SZ, Gold PW, Chrousos GP. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss.  J Clin Endocrinol Metab. 1997;  82 1874-1878
  CrossrefPubMedGoogle Scholar
• 22 Vertes V, Genuth SM, Hazelton IM. Supplemented fasting as a large-scale outpatient program.  JAMA. 1977;  238 2151-2153
  CrossrefPubMedGoogle Scholar
• 23 Mattson MP, Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems.  J Nutr Biochem. 2005;  16 129-137
  PubMedGoogle Scholar
• 24 Ho JT, Al Musalhi H, Chapman MJ, Quach T, Thomas PD, Bagley CJ. et al . Septic shock and sepsis: a comparison of total and free plasma cortisol levels.  J Clin Endocrinol Metab. 2006;  91 105-114
  CrossrefPubMedGoogle Scholar
• 25 Lewis JG, Lewis MG, Elder PA. An enzyme-linked immunosorbent assay for corticosteroid-binding globulin using monoclonal and polyclonal antibodies: decline in CBG following synthetic ACTH.  Clin Chim Acta. 2003;  328 ((1-2)) 121-128
  CrossrefPubMedGoogle Scholar
• 26 Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M. et al . Weight loss and the renin-angiotensin-aldosterone system.  Hypertension. 2005;  45 356-362
  CrossrefPubMedGoogle Scholar
• 27 Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system.  Am J Hypertens. 1989;  2 ((3 Pt 2)) 125S-132S
  PubMedGoogle Scholar
• 28 Weinberger MH. Salt sensitivity of blood pressure in humans.  Hypertension. 1996;  27 ((3 pt 2)) 481-490
  PubMedGoogle Scholar
• 29 Midley JP, Matthew G, Greenwood CMT, Logan AG. Effects of reduced dietary salt on blood pressure: A meta analysis of randomised controlled trials.  J Amer Med Assoc. 1996;  275 1590-1597
  CrossrefPubMedGoogle Scholar
• 30 He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure.  Cochrane Database Syst Rev. 2004;  ((3)) CD004937
  PubMedGoogle Scholar
• 31 Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long term issues.  Hypertension. 1991 Jan;  17 ((1 Suppl)) I61-I68
  PubMedGoogle Scholar

Correspondence

Dr. J. T. Ho

Endocrine and Metabolic Unit

Royal Adelaide Hospital

North Terrace

5000 Adelaide

South Australia

Australia

Phone: +61/08/8222 55 20

Fax: +61/08/8222 59 08

Email: jui.ho@imvs.sa.gov.au